Disulfide-directed multicyclic peptides for chimeric antigen receptors targeting solid tumors
RNA-seq (gene expression) · human · 27 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 27 samples: 9 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE314995_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1367362 and SRA study SRP652853. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 27 samples.
How we read this: 9 replicated groups read from 27 sample titles; they account for 27 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9419880 UT-A549-TROP2-3 UT-A549-TROP2
- GSM9419881 TROP2(DDMP)-CAR7-A549-TROP2-1 TROP2(DDMP)-CAR7-A549-T…
- GSM9419882 TROP2(scFv)-CAR7-A549-TROP2-1 TROP2(scFv)-CAR7-A549-T…
- GSM9419883 TROP2(DDMP)-CAR6-A549-TROP2-1 TROP2(DDMP)-CAR6-A549-T…
- GSM9419884 TROP2(scFv)-CAR6-A549-TROP2-1 TROP2(scFv)-CAR6-A549-T…
- GSM9419885 UT-OE19-1 UT-OE19
- GSM9419886 HER2(DDMP)-OE19-1 HER2(DDMP)-OE19
- GSM9419887 HER2(scFv)-OE19-1 HER2(scFv)-OE19
- GSM9419888 HER2(scFv′)-OE19-1 HER2(scFv′)-OE19
- GSM9419889 UT-A549-TROP2-1 UT-A549-TROP2
- GSM9419890 TROP2(DDMP)-CAR7-A549-TROP2-2 TROP2(DDMP)-CAR7-A549-T…
- GSM9419891 TROP2(scFv)-CAR7-A549-TROP2-2 TROP2(scFv)-CAR7-A549-T…
- GSM9419892 TROP2(DDMP)-CAR6-A549-TROP2-2 TROP2(DDMP)-CAR6-A549-T…
- GSM9419893 TROP2(scFv)-CAR6-A549-TROP2-2 TROP2(scFv)-CAR6-A549-T…
- GSM9419894 UT-OE19-2 UT-OE19
- GSM9419895 HER2(DDMP)-OE19-2 HER2(DDMP)-OE19
- GSM9419896 HER2(scFv)-OE19-2 HER2(scFv)-OE19
- GSM9419897 HER2(scFv′)-OE19-2 HER2(scFv′)-OE19
- GSM9419898 UT-A549-TROP2-2 UT-A549-TROP2
- GSM9419899 TROP2(DDMP)-CAR6-A549-TROP2-3 TROP2(DDMP)-CAR6-A549-T…
- GSM9419900 TROP2(scFv)-CAR6-A549-TROP2-3 TROP2(scFv)-CAR6-A549-T…
- GSM9419901 UT-OE19-3 UT-OE19
- GSM9419902 HER2(DDMP)-OE19-3 HER2(DDMP)-OE19
- GSM9419903 HER2(scFv)-OE19-3 HER2(scFv)-OE19
- GSM9419904 HER2(scFv′)-OE19-3 HER2(scFv′)-OE19
- GSM9419905 TROP2(DDMP)-CAR7-A549-TROP2-3 TROP2(DDMP)-CAR7-A549-T…
- GSM9419906 TROP2(scFv)-CAR7-A549-TROP2-3 TROP2(scFv)-CAR7-A549-T…
- GSE313197 Tumor Antigen–Independent Targeting of Solid Tumors by Armored 1 Macrophage-Directed anti-TREM2-CAR T Cells [human scRNA-seq] 23 samples shares targeting, antigen, solid
- GSE294657 Chimeric antigen receptor-microglia targeting glioblastoma within cortical organoid 4 samples shares targeting, chimeric, antigen
- GSE284664 RESET: A reversible TCR-coupled antigen receptor with superior targeting sensitivity and pharmacologically controlled anti-tumor activity 62 samples shares targeting, antigen
- GSE280810 Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and anti-tumoral activity upon IL-10 or TGFβ stimulation 30 samples shares receptors, chimeric
- GSE268157 Mis-splicing derived neoantigens and cognate T cell receptors in splicing factor mutant leukemias 54 samples shares receptors, antigen
- GSE240656 Multi-center Korean cohort study based on RNA-sequencing data targeting COPD patients 294 samples shares targeting
- GSE281471 Targeting CD206+ macrophages disrupts the establishment of a key anti-tumor immune axis [Bulk RNA-seq] 243 samples shares targeting
- GSE338964 Computational modeling and preclinical evaluation support targeting somatic instability for Huntington’s disease treatment. 104 samples shares targeting
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.